Clinical Trials Browser

OTHER × Hepatitis B × peginterferon alfa-2b × Clear all

NCT07553767 2026-04-28

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic